Non‐alcoholic fatty liver disease: raising awareness of a looming public health problem

Lucy Gracen and Elizabeth E Powell
Med J Aust 2021; 215 (2): . || doi: 10.5694/mja2.51109
Published online: 19 July 2021

In Australia, there is a paucity of coordinated strategies for preventing, detecting, and managing NAFLD

Despite being the most frequent cause of chronic liver disease in Australia, the prevalence and clinical consequences of non‐alcoholic fatty liver disease (NAFLD) remain uncertain.1 Accurate population‐based data on the burden of NAFLD are crucial for guiding public health strategies and directing health care resources to reducing the incidence of NAFLD and associated metabolic conditions.

  • Lucy Gracen1,2
  • Elizabeth E Powell1,2

  • 1 Centre for Liver Disease Research, Translational Research Institute Australia, Brisbane, QLD
  • 2 Princess Alexandra Hospital, Brisbane, QLD



Lucy Gracen is supported by a PA Research Foundation research award (2021).

Competing interests:

Elizabeth Powell has received an unrestricted grant from Siemens Healthineers.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.